International Cardiovascular Research Journal

Published by: Kowsar

Lectin-like Oxidized LDL Receptor-1 (LOX-1) Protein Vaccination Reduces Inflammation and Attenuates Atherosclerosis Progression in Atherogenic-Diet Wistar Rats

Oktavia Rahayu Adianingsih 1 , Fredo Tamara 1 , Ardina Pramesti Putri 1 , Angi Nurkhairina 1 , Thoha Muhajir Albaar 1 , Maimun Zulhaidah Arthamin 2 and Valentina Yurina 2 , *
Authors Information
1 Faculty of Medicine, Brawijaya University, Malang, Indonesia
2 Pathology Clinic Laboratory, Faculty of Medicine, Brawijaya University, Malang, Indonesia
Article information
  • International Cardiovascular Research Journal: 10 (4); e9803
  • Published Online: October 1, 2016
  • Article Type: Research Article
  • Received: November 25, 2015
  • Revised: April 15, 2016
  • Accepted: July 17, 2016

To Cite: Adianingsih O R, Tamara F, Putri A P, Nurkhairina A, Albaar T M, et al. Lectin-like Oxidized LDL Receptor-1 (LOX-1) Protein Vaccination Reduces Inflammation and Attenuates Atherosclerosis Progression in Atherogenic-Diet Wistar Rats, Int Cardio Res J. Online ahead of Print ; 10(4):e9803.

Copyright © 2016, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Mozaffarian. . Heart disease and stroke statistics-2015 update: A report from the american heart association (vol 131, pg e29, 2015). Circulation. 2015; 131(24): 535
  • 2. Ding Z, Liu S, Wang X, Dai Y, Khaidakov M, Romeo F, et al. LOX-1, oxidant stress, mtDNA damage, autophagy, and immune response in atherosclerosis. Can J Physiol Pharmacol. 2014; 92(7): 524-30[DOI][PubMed]
  • 3. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res. 2006; 69(1): 36-45[DOI][PubMed]
  • 4. Yoshimoto R, Fujita Y, Kakino A, Iwamoto S, Takaya T, Sawamura T. The discovery of LOX-1, its ligands and clinical significance. Cardiovasc Drugs Ther. 2011; 25(5): 379-91[DOI][PubMed]
  • 5. Mango R, Predazzi IM, Romeo F, Novelli G. LOX-1/LOXIN: the yin/yang of atheroscleorosis. Cardiovasc Drugs Ther. 2011; 25(5): 489-94[DOI][PubMed]
  • 6. Pirillo A, Norata GD, Catapano AL. LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm. 2013; 2013: 152786[DOI][PubMed]
  • 7. LOX-1, a lectin-like oxidized LDL receptor identified form endothelial cells, in endothelial dysfunction. International Congress Series. : 531-4
  • 8. Gaofu Q, Jun L, Xin Y, Wentao L, Jie W, Xiuyun Z, et al. Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-Cell epitope carried by heat shock protein-65 (HSP65) for inducing anti-CETP antibodies and reducing aortic lesions in vivo. J Cardiovasc Pharmacol. 2005; 45(6): 591-8[PubMed]
  • 9. Liaw YW, Lin CY, Lai YS, Yang TC, Wang CJ, Whang-Peng J, et al. A vaccine targeted at CETP alleviates high fat and high cholesterol diet-induced atherosclerosis and non-alcoholic steatohepatitis in rabbit. PLoS One. 2014; 9(12)[DOI][PubMed]
  • 10. Mao D, Kai G, Gaofu Q, Zheng Z, Li Z, Jie W, et al. Intramuscular immunization with a DNA vaccine encoding a 26-amino acid CETP epitope displayed by HBc protein and containing CpG DNA inhibits atherosclerosis in a rabbit model of atherosclerosis. Vaccine. 2006; 24(23): 4942-50[DOI][PubMed]
  • 11. Rittershaus CW, Miller DP, Thomas LJ, Picard MD, Honan CM, Emmett CD, et al. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol. 2000; 20(9): 2106-12[PubMed]
  • 12. Tissot AC, Spohn G, Jennings GT, Shamshiev A, Kurrer MO, Windak R, et al. A VLP-based vaccine against interleukin-1alpha protects mice from atherosclerosis. Eur J Immunol. 2013; 43(3): 716-22[DOI][PubMed]
  • 13. Hauer AD, van Puijvelde GH, Peterse N, de Vos P, van Weel V, van Wanrooij EJ, et al. Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 2007; 27(9): 2050-7[DOI][PubMed]
  • 14. El-Shatanovi G, Ashoush I, Ahmed EK, Ali SA. Antiatherogenic properties of vegetable juice rich in antioxidants in cholesterol-fed rats. Annal Agricultural Sci. 2012; 57(2): 167-73
  • 15. Shirai K, Ishikawa Y, Nishide T, Sasaki N, Murano S, Sato A, et al. Effect of niceritrol on lipid metabolism of aorta in atherosclerotic rats. Tohoku J Exp Med. 1984; 143(2): 231-8
  • 16. Handayani D, Chen J, Meyer BJ, Huang XF. Dietary Shiitake Mushroom (Lentinus edodes) Prevents Fat Deposition and Lowers Triglyceride in Rats Fed a High-Fat Diet. J Obes. 2011; 2011: 258051[DOI][PubMed]
  • 17. Handayani D, Meyer BJ, Chen J, Tang P, Kwok PCL, Chan HK, et al. The comparison of the effect of oat and Shiitake mushroom powder to prevent body weight gain in rats fed high fat diet. Food Nutr Sci. 2012;
  • 18. Fredrikson GN, Bjorkbacka H, Soderberg I, Ljungcrantz I, Nilsson J. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies. J Intern Med. 2008; 264(6): 563-70[DOI][PubMed]
  • 19. Pauwels R, Bazin H, Platteau B, Van der Straeten M. The influence of antigen dose on IgE production in different rat strains. Immunol. 1979; 36(1): 151
  • 20. Wigren M, Bengtsson D, Duner P, Olofsson K, Bjorkbacka H, Bengtsson E, et al. Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells. Circ Res. 2009; 104(12): 62-70[DOI][PubMed]
  • 21. Wigren M, Kolbus D, Duner P, Ljungcrantz I, Soderberg I, Bjorkbacka H, et al. Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine. J Intern Med. 2011; 269(5): 546-56[DOI][PubMed]
  • 22. Sawamura T, Wakabayashi I, Okamura T. LOX-1 in atherosclerotic disease. Clin Chim Acta. 2015; 440: 157-63[DOI][PubMed]
  • 23. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, Kardakaris R, et al. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab. 2008; 8(5): 372-83[DOI][PubMed]
  • 24. Xu X, Gao X, Potter BJ, Cao JM, Zhang C. Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice. Arterioscler Thromb Vasc Biol. 2007; 27(4): 871-7[DOI][PubMed]
  • 25. Sugimoto K, Ishibashi T, Sawamura T, Inoue N, Kamioka M, Uekita H, et al. LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells. Cardiovasc Res. 2009; 84(1): 127-36[DOI][PubMed]
  • 26. Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 2012; 483(7390): 479-83
  • 27. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011; 473(7347): 317-25[DOI][PubMed]
  • 28. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011; 17(11): 1410-22[DOI][PubMed]
  • 29. Brito LA, O'Hagan DT. Designing and building the next generation of improved vaccine adjuvants. J Control Release. 2014; 190: 563-79[DOI][PubMed]
  • 30. De Gregorio E, Caproni E, Ulmer JB. Vaccine adjuvants: mode of action. Front Immunol. 2013; 4: 214[DOI][PubMed]
  • 31. Kool M, Fierens K, Lambrecht BN. Alum adjuvant: some of the tricks of the oldest adjuvant. J Med Microbiol. 2012; 61: 927-34[DOI][PubMed]
  • 32. Hauer AD, Habets KL, van Wanrooij EJ, de Vos P, Krueger J, Reisfeld RA, et al. Vaccination against TIE2 reduces atherosclerosis. Atherosclerosis. 2009; 204(2): 365-71[DOI][PubMed]
  • 33. O'Brien C. Vaccine for atherosclerosis. Mol Med Today. 1997; 3(6): 231[PubMed]
  • 34. Petrovan RJ, Kaplan CD, Reisfeld RA, Curtiss LK. DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2007; 27(5): 1095-100[DOI][PubMed]
  • 35. Tsiantoulas D, Diehl CJ, Witztum JL, Binder CJ. B cells and humoral immunity in atherosclerosis. Circ Res. 2014; 114(11): 1743-56[DOI][PubMed]
  • 36. Shaw DJ, Seese R, Ponnambalam S, Ajjan R. The role of lectin-like oxidised low-density lipoprotein receptor-1 in vascular pathology. Diab Vasc Dis Res. 2014; 11(6): 410-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments